The Brca1F22-24 allele has loxP sites flanking exons 22-24 of the Brca1 gene. These mice may be useful in generating tissue-specific BRCA1 deletions for studying basal-like cancer and breast cancer.
IMR Colony, The Jackson Laboratory
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Conditional ready (e.g. floxed), No functional change) | Brca1 | breast cancer 1, early onset |
The Brca1F22-24/F22-24 allele has loxP sites flanking exons 22-24 of the breast cancer 1 gene (Brca1). Homozygous Brca1F22-24/F22-24 mice are viable and fertile with no observed abnormalities. When bred to mice that express Cre recombinase, the resulting offspring will have the sequences encoding the second terminal BRCT domain deleted in the cre-expressing tissue(s). These Brca1F22-24/F22-24 mice may be useful in generating tissue-specific BRCA1 deletions for studying human basal-like cancer and breast cancer.
For example, when crossed to a strain expressing Cre recombinase in mammary gland during lactation (see Stock No. 017836), mice exhibit increased mammary gland tumor incidence.
The Brca1F22-24 targeted mutation was designed by Dr. Alan Ashworth (Breakthrough Breast Cancer Research Centre, London) to replace exons 22-24 of the mouse breast cancer 1 gene (Brca1) with a loxP site, a cDNA sequence encoded by exons 22-24, a 3' myc epitope, bovine growth hormone polyA signal, a second loxP site, a splice acceptor sequence, and a PGK-neo cassette. This construct was electroporated into (129X1/SvJ x 129S1/Sv)F1-Kitl+-derived R1 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts and the resulting chimeric mice were bred to C57BL/6 mice. These mice were intercrossed to establish a colony of Brca1F22-24/F22-24 mice on a mixed background.
Brca1F22-24 mice were bred to C57BL/6;129S7-Trp53tm1Brd and C57BL/6;CBA-Tg(LGB-cre)74Acl mice, and the resulting triple mutant mice were sent to The Jackson Laboratory Repository as Stock No. 012620. Upon arrival, some mice were selectively bred with wildtype mice from the colony or with C57BL/6J inbred mice (Stock No. 000664) to generate this Brca1F22-24 single mutant colony (as Stock No. 017835).
Allele Name | targeted mutation 1, Alan Ashworth |
---|---|
Allele Type | Targeted (Conditional ready (e.g. floxed), No functional change) |
Allele Synonym(s) | Brca1F22-24 |
Gene Symbol and Name | Brca1, breast cancer 1, early onset |
Gene Synonym(s) | |
Site of Expression | mammary epithelial cells |
Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ |
Chromosome | 11 |
Molecular Note | Exons 22-24 were replaced with a floxed sequence containing cDNA for exons 22-24 with an in frame myc epitope and a bovine growth hormone poly A sequence. This vector allows conditional excision of the second, terminal BRCT domain. Downstream of the floxed sequence, a splice acceptor and PGK-neo were inserted. |
Mutations Made By | Alan Ashworth, University of California, San Francisco |
When maintaining a live colony, mice homozygous for the Brca1F22-24/F22-24 allele may be bred together.
When using the Brca1F22-24 mouse strain in a publication, please cite the originating article(s) and include JAX stock #017835 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous for Brca1<tm1Aash> |
Frozen Mouse Embryo | STOCK Brca1<tm1Aash>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Brca1<tm1Aash>/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | STOCK Brca1<tm1Aash>/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | STOCK Brca1<tm1Aash>/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.